We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Explore Yupelri (revefenacin), a long-acting muscarinic antagonist (LAMA) nebulizer solution for chronic obstructive pulmonary disease (COPD). Learn about its uses, dosage, side effects, and benefits in managing airflow obstruction and improving lung function.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing difficult. Millions worldwide grapple with its debilitating symptoms, which can significantly impact quality of life. Fortunately, advancements in medical science continue to offer new hope and effective treatment options. One such innovation is Yupelri (revefenacin), a long-acting muscarinic antagonist (LAMA) approved for the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD.
This comprehensive guide delves into Yupelri, exploring its mechanism of action, how it’s used, its benefits, potential side effects, and important considerations for patients. Our aim is to provide you with a factual and easy-to-understand resource to help you and your healthcare provider make informed decisions about managing your COPD.
COPD is an umbrella term for a group of progressive lung diseases that block airflow and make it difficult to breathe. The most common conditions under COPD are emphysema and chronic bronchitis. Damage to the lungs from COPD is often irreversible and worsens over time. It is primarily caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke.
Symptoms often develop slowly and worsen over time. They can include:
Early diagnosis and appropriate treatment are crucial for managing symptoms and slowing disease progression.
Yupelri contains the active ingredient revefenacin, which belongs to a class of medications called long-acting muscarinic antagonists (LAMAs). LAMAs are a type of bronchodilator, meaning they help to relax the muscles around the airways in your lungs, allowing them to open up and making it easier to breathe.
In COPD, the airways often become inflamed and constricted, making it harder for air to flow in and out of the lungs. This constriction is partly due to the action of acetylcholine, a neurotransmitter that stimulates muscarinic receptors in the airway smooth muscle, leading to bronchoconstriction.
Revefenacin works by blocking these muscarinic receptors (specifically M3 receptors) in the lungs. By blocking acetylcholine from binding to these receptors, revefenacin prevents the contraction of airway smooth muscles and reduces mucus secretion, leading to bronchodilation. Because it’s a long-acting medication, its effects last for approximately 24 hours, allowing for convenient once-daily dosing.
Yupelri is administered as a solution for nebulization. A nebulizer is a small machine that turns liquid medicine into a fine mist that you inhale through a mouthpiece or mask. This method delivers the medication directly to your lungs, where it can act quickly and effectively.
The recommended dosage of Yupelri is one single-use vial (175 mcg of revefenacin) administered once daily via a standard jet nebulizer connected to an air compressor. It is important to use Yupelri consistently every day, at the same time, to maintain its therapeutic effects.
Always follow your doctor's instructions and the specific instructions provided with your nebulizer device.
Clinical studies have demonstrated Yupelri's effectiveness in improving lung function and reducing symptoms in patients with COPD.
In pivotal clinical trials, Yupelri significantly improved forced expiratory volume in one second (FEV1), a key measure of lung function, compared to placebo. This improvement in FEV1 indicates that Yupelri helps to open the airways, allowing more air to move in and out of the lungs.
Patients treated with Yupelri reported improvements in symptoms such as shortness of breath and a reduction in the need for rescue medication. The once-daily dosing regimen also contributes to better treatment adherence and convenience for patients.
As a long-acting bronchodilator, Yupelri is designed for long-term maintenance treatment. It helps to keep airways open consistently, which is crucial for preventing exacerbations (flare-ups) and maintaining stable breathing throughout the day and night.
Like all medications, Yupelri can cause side effects, although not everyone experiences them. It's important to discuss any concerns with your healthcare provider.
The most commonly reported side effects in clinical trials (occurring in 2% or more of patients and more often than with placebo) include:
These side effects are generally mild to moderate and often resolve on their own.
While rare, more serious side effects can occur. Seek immediate medical attention if you experience any of the following:
It’s crucial to inform your doctor about all your medical conditions and medications before starting Yupelri.
Yupelri is contraindicated in patients with a history of hypersensitivity to revefenacin or any components of the product.
Yupelri is a maintenance treatment and should NOT be used for the relief of acute bronchospasm (sudden breathing problems). You should have a rescue inhaler readily available for such episodes.
Like other anticholinergic medications, Yupelri can cause cardiovascular effects such as increased heart rate, blood pressure, or irregular heart rhythm. Use with caution in patients with cardiovascular disease.
Tell your doctor about all the medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. While Yupelri has a low potential for drug-drug interactions due to its low systemic absorption, it's always best to disclose your full medication list.
It's important to maintain regular communication with your healthcare provider when managing COPD and using Yupelri. You should contact your doctor if:
Do not stop using Yupelri without consulting your doctor, even if you feel better, as this could lead to a worsening of your symptoms.
Managing COPD effectively involves more than just medication. A holistic approach can significantly improve your quality of life.
No, Yupelri is not a rescue medication. It is a long-term maintenance treatment for COPD and should not be used to treat sudden breathing problems. Always keep a rescue inhaler handy for acute symptoms.
Yupelri begins to work within minutes of inhalation, but its full bronchodilatory effects are sustained over 24 hours with consistent daily use.
Your doctor will determine if Yupelri can be used safely with your other COPD medications. It is often prescribed as part of a broader treatment plan. Always inform your doctor about all medications you are taking.
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed dose.
Store Yupelri vials in the foil pouch at room temperature, protected from light and excessive heat. Do not open the foil pouch until you are ready to use a dose. Once the pouch is opened, use the vial within 7 days. Once a vial is opened, use it immediately and discard any remaining solution.
Yupelri (revefenacin) offers a valuable once-daily nebulized treatment option for individuals living with COPD. By providing sustained bronchodilation, it helps to alleviate airflow obstruction, reduce symptoms, and improve lung function, thereby enhancing the quality of life for many patients. While generally well-tolerated, it is crucial to understand its proper use, potential side effects, and when to seek medical attention.
Always work closely with your healthcare provider to develop a personalized COPD management plan that includes appropriate medications like Yupelri, lifestyle adjustments, and regular monitoring. With consistent care and adherence to treatment, managing COPD effectively is an achievable goal.
Visit Hospital
Near You
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026